Drug/Insect/Latex News

Children who experience a persistent allergy to cow’s milk are more likely to have a lower weight and height than children with peanut and tree nut allergies, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.

Children who experience food allergies are not at an increased risk of using emergency care from EDs or hospitalization when compared with other children with asthma, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology in Orlando

Folic acid exposure in utero may be associated with food allergy development in children, according to research presented at the American Academy of Allergy, Asthma & Immunology in Orlando.

Patients who have other allergic diseases are more likely to develop eosinophilic esophagitis, according to research presented at the 2018 American Academy of Allergy, Asthma & Immunology and World Allergy Organization Joint Congress.

AR101, an immunotherapy treatment option for peanut allergy created by Aimmune Therapeutics Inc. is effective in increasing tolerance to peanut protein in children aged between 4 and 17 years, with 67.2% of children tolerating up to 600 mg of peanut protein, according to phase 3 study results released by the company.

Infants of mothers who consume peanuts while breast-feeding and directly introduce their child to the food by 12 months of age are less likely to be sensitized to peanuts, according to a study published in The Journal of Allergy and Clinical Immunology.

New data have affirmed what the American College of Allergy, Asthma and Immunology said has been known for several years: There are no special precautions needed to dispense the influenza vaccine in people with egg allergy.

Patients with peanut sensitivity who wore a 250-µg epicutaneous immunotherapy-based peanut patch had a significant treatment response compared to patients wearing patches with smaller doses or placebo, according to phase 2b trial findings recently published in JAMA.

BOSTON — The implementation of an outpatient chemotherapy desensitization program appeared safe and significantly reduced the mean time from arrival to desensitization in patients with hypersensitive reactions to chemotherapy, according to study results presented at the ACAAI Annual Scientific Meeting.

BOSTON - Approximately half of 40,447 food-allergic adults reported one or more adult-onset food allergies, according to findings presented at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting.